This Psychedelics Company Begins Trading On NASDAQ With $7.5M Offering Then Reverse Stock Split
Psychedelics biotech firm Clearmind Medicine Inc.
Meta Offers To Exchange Unregistered Debt Notes For Registered Notes
Meta Platforms, Inc (NASDAQ: META) has offered to exchange current unregistered senior notes of various due dates with registered secured notes of similar dates and values as there is no public market currently for the unregistered notes.
Ideanomics Secured Third-party Financing to Accelerate Growth of Solectrac’s Dealer Network
Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles (EV), today announces that its subsidiary Solectrac has added seven more certified dealers to its dealer network.
Silver Spike Investment Corp. Reports Second Quarter Fiscal 2023 Financial Results
On Thursday, Silver Spike Investment Corp. (NASDAQ: SSIC), a specialty finance company announced its financial results for the quarter ended September 30, 2022.
FibroGen Announces $50M Royalty Monetization Financing With NovaQuest Capital Management
Strengthens balance sheet with strategic non-dilutive capital to support strategic priorities
Supported by global launches of EVRENZO™ in the territories partnered with Astellas Pharma
EXCLUSIVE: Orgenesis’ Subsidiary Secures $50M Investment To Accelerate Point-of-Care Services Growth
Private equity Metalmark Capital Partners has agreed to invest up to $50 million in Orgenesis Inc's U.S.-based (NASDAQ: ORGS) point of care services subsidiary, Morgenesis LLC.
Rain Therapeutics Experimental Cancer Therapy Shows Encouraging Tumor Regression Activity
Rain Therapeutics Inc (NASDAQ:RAIN) announced preliminary data from Phase 2 basket trial evaluating milademetan for MDM2-amplified advanced solid tumors. “Treatment…
Middle Eastern Investors May Own A Fourth In Credit Suisse, As Qatar Investment Mulls Raising Stake
The Qatar Investment Authority (QIA) may increase its stake in Credit Suisse Group Inc (NYSE: CS) by investing in a share sale alongside Saudi National Bank.
Ketamine Therapy: Revitalist’s New Financing Option, Irwin Naturals Expands Chain Of Clinics
Revitalist Increases Patient Access By Financing Costs With M-Lend Financial
Marinus Pharmaceuticals Announces $32.5M Revenue Interest Financing Agreement With Sagard Healthcare Partners
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it has entered into a revenue interest